Sunbelt Securities »

Candel Therapeutics shares owned by Sunbelt Securities

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Sunbelt Securities from 13F filings

Historical chart of Sunbelt Securities investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Sunbelt Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Sunbelt Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $137 27 5.11

More positions owned by Sunbelt Securities

Exxon Mobil Corp Stock (XOM)
Nvidia Corporation Stock (NVDA)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Ishares Gold Trust Etf (IAU)
Broadcom Stock (AVGO)
Ishares S&p 500 Growth Etf Etf (IVW)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Invesco Qqq Trust Series I Etf (QQQ)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Ishares Core S&p 500 Etf Etf (IVV)
Amazon Stock (AMZN)
Spdr S&p 500 Etf Trust Etf (SPY)
Palantir Technologies Inc Cl A Stock (PLTR)
Innovator Defined Wealth Shield Etf Etf (BALT)

View all positions for Sunbelt Securities

Top funds holding Candel Therapeutics

FMR
Acorn Capital Advisors
BlackRock
Vanguard Group
Portolan Capital Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Citadel Advisors
Sands Capital Ventures
Susquehanna International
Northern Trust
Nuveen
Tanager Wealth Management
Wellington Management Company

View all funds holding Candel Therapeutics